Back The Council of Europe´s MEDICRIME Committee adopts a MEDICRIME strategy for 2024-2025

The Council of Europe´s MEDICRIME Committee adopts a MEDICRIME strategy for 2024-2025

Responding to the evolving nature of counterfeit/falsified medical products and other similar crimes involving threats to public health in Europe and beyond, the Council of Europe´s MEDICRIME Committee adopted a MEDICRIME strategy for 2024-2025 which offers new tools and concrete responses to continuous and emerging challenges faced by state authorities.

The strategy aims at strengthening efforts in Europe and beyond by addressing not only the phenomenon of counterfeit/falsified medical products but also its root causes and their promotion, particularly on online media. The strategy also reflects the understanding that consumers begin to believe these to be legitimate and cheaper alternatives than professional medical diagnosis and treatment. This can be reinforced by national authorities seeing the threat as routine rather than something requiring targeted attention. This masks the gravity of the risk to public health that become more obvious when a crisis arises, such the COVID-19 pandemic.

To address these complex issues, the strategy envisages a rounded approach consisting of 13 actions targeted at strengthening preventive, repressive and protection capacities of national authorities through the development of a set of binding and non-binding legal standards, analytical reports, and model tools. In particular, it also aims at promoting the Convention, preventing the counterfeiting/falsification of medical products and similar crimes and prosecuting the manufacturers, suppliers and those enabling the trafficking of counterfeit/falsified medical products and similar crimes involving threats to public health.

The strategy stresses the need for the respect of human rights and the rule of law, as well as due consideration for the victims from the crimes of counterfeit/falsified medical products and similar crimes. It also emphasises the need for cross-sectoral and cross-border co-operation by taking into consideration a dedicated mechanism to execute international cooperation requests and help law enforcement and judicial cooperation rapidly exchange vital investigative information and facilitate evidence collection in other States.

The new strategy will be implemented by the MEDICRIME Committee, in close co-operation and co-ordination with other relevant international organisations and Council of Europe bodies.

 MEDICRIME Strategy 2024-2025

Strasbourg 15 January 2024
  • Diminuer la taille du texte
  • Augmenter la taille du texte
  • Imprimer la page
Covid 19

At a time when the Covid-19 epidemic is posing unprecedented challenges to the health sector, the Council of Europe calls on governments to be extremely vigilant against counterfeit or falsified medicines and medical products. Faced with this threat, states can rely on the MEDICRIME Convention to safeguard public health and target the criminal behaviour of those who, like criminal networks, take advantage of the loopholes in our systems and of the current crisis.

Handbook for Parliamentarians

English - Français - Русский - Español

Handbook for Parliamentarians

SaveSave
SaveSave

"In recent years, occurrences of counterfeiting of medical products and similar crimes have increased worldwide. These crimes endanger public health, and affect patients and their confidence in the legal marketplace.

Even more profitable than drug trafficking, this new form of crime has an undeniable advantage for criminals: they go largely unpunished or receive only mild sanctions. Even when states take strict measures to regulate the production and distribution of medical products and devices, these measures often prove insufficient, especially when criminal networks find gaps in national legislations allowing them to make substantial profits at the expense of people’s lives and health. The MEDICRIME Convention was drafted to protect vulnerable patients and their right to safe access to medicines of appropriate quality, and to fight against organised crime. As the first and only international treaty dealing with this problem, the convention aims at prosecuting the counterfeiting of medical products and similar crimes, protecting the rights of victims and promoting national and international co-operation."

Gabriella Battaini-Dragoni
Deputy Secretary General of the Council of Europe